Symphony Asset Management’s Eastman Chemical EMN Stock Holding History

Symphony Asset Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-14,139	Closed	-$1.14M	–	426
2013 Q4	$1.14M	Sell	14,139 -5,274	-27%	-$409K	0.08%	196
2013 Q3	$1.51M	Buy	19,413 +1,943	+11%	+$150K	0.15%	141
2013 Q2	$1.22M	Buy	+17,470	New	+$1.22M	0.12%	161

Other funds holding EMN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Symphony Asset Management's EMN Position: Q1 2014 in Review

Symphony Asset Management sold out of Eastman Chemical (EMN) in Q1 2014, closing a stake of 14,139 shares — an estimated $1.14M sold.

Symphony Asset Management first reported a position in EMN in Q2 2013 and held it in 3 quarters. The position peaked at $1.51M in Q3 2013. 543 funds tracked by Wall St. Rank hold EMN as of Q1 2014.

Symphony Asset Management reported no remaining Eastman Chemical position as of Q1 2014 after selling out during the quarter.
Symphony Asset Management sold 14,139 Eastman Chemical shares in Q1 2014, an estimated $1.14M.
Symphony Asset Management first reported a position in Eastman Chemical in Q2 2013 and held it in 3 quarters.
Symphony Asset Management's Eastman Chemical position peaked at $1.51M in Q3 2013.
543 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2014.

Based on Symphony Asset Management's 13F filing for Q1 2014, filed 15 May 2014.